학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 38건 | 목록 1~20
Academic Journal
Rasco DW; South Texas Accelerated Research Therapeutics, LLC, San Antonio, TX, USA.; Medina T; University of Colorado Cancer Center, Aurora, CO, USA.; Corrie P; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Pavlick AC; Laura & Isaac Perlmutter Cancer Center at NYU Langone, New York, NY, USA.; Middleton MR; Department of Oncology, NIHR Biomedical Research Centre, Oxford, UK.; Lorigan P; The Christie NHS Foundation Trust and Division of Cancer Sciences, University of Manchester, Manchester, UK.; Hebert C; Bristol Haematology and Oncology Centre, Bristol, UK.; Plummer R; The Northern Centre for Cancer Care, Freeman Hospital, Newcastle upon Tyne, UK.; Larkin J; The Royal Marsden Hospital, London, UK.; Agarwala SS; St. Luke's Cancer Center and Temple University, Easton, PA, USA.; Daud AI; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.; Qiu J; Day One Biopharmaceuticals, 2000 Sierra Point Parkway, Suite 501, Brisbane, CA, 94005, USA.; Bozon V; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.; Kneissl M; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.; Barry E; Day One Biopharmaceuticals, 2000 Sierra Point Parkway, Suite 501, Brisbane, CA, 94005, USA. elly.barry@dayonebio.com.; Olszanski AJ; Fox Chase Cancer Center, Philadelphia, PA, USA.
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE
Academic Journal
Patnaik A; START, 4383 Medical Drive, Suite 4026, San Antonio, TX, 78229, USA. amita.patnaik@startsa.com.; Gadgeel S; Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA.; Henry Ford Health System, Detroit, MI, USA.; Papadopoulos KP; START, 4383 Medical Drive, Suite 4026, San Antonio, TX, 78229, USA.; Rasco DW; START, 4383 Medical Drive, Suite 4026, San Antonio, TX, 78229, USA.; Haas NB; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Der-Torossian H; Mirati Therapeutics Inc., San Diego, CA, USA.; Faltaos D; Mirati Therapeutics Inc., San Diego, CA, USA.; Olema Therapeutics, San Francisco, CA, USA.; Potvin D; Mirati Therapeutics Inc., San Diego, CA, USA.; Tassell V; Mirati Therapeutics Inc., San Diego, CA, USA.; Tawashi M; Mirati Therapeutics Inc., San Diego, CA, USA.; HUYABIO International, San Diego, CA, USA.; Chao R; Mirati Therapeutics Inc., San Diego, CA, USA.; O'Dwyer PJ; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE
Patnaik A; START, 4383 Medical Drive, Suite 4026, San Antonio, TX, 78229, USA. amita.patnaik@startsa.com.; Gadgeel S; Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA.; Henry Ford Health System, Detroit, MI, USA.; Papadopoulos KP; START, 4383 Medical Drive, Suite 4026, San Antonio, TX, 78229, USA.; Rasco DW; START, 4383 Medical Drive, Suite 4026, San Antonio, TX, 78229, USA.; Haas NB; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Der-Torossian H; Mirati Therapeutics Inc., San Diego, CA, USA.; Faltaos D; Mirati Therapeutics Inc., San Diego, CA, USA.; Olema Therapeutics, San Francisco, CA, USA.; Potvin D; Mirati Therapeutics Inc., San Diego, CA, USA.; Tassell V; Mirati Therapeutics Inc., San Diego, CA, USA.; Tawashi M; Mirati Therapeutics Inc., San Diego, CA, USA.; HUYABIO International, San Diego, CA, USA.; Chao R; Mirati Therapeutics Inc., San Diego, CA, USA.; O'Dwyer PJ; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE; PubMed not MEDLINE
Academic Journal
Patnaik A; South Texas Accelerated Research Therapeutics, San Antonio, TX, USA. Amita.Patnaik@startsa.com.; Weiss GJ; Western Regional Medical Center, Cancer Treatment Centers of America, Goodyear, AZ, USA.; SOTIO, LLC, Cambridge, MA, USA.; Rasco DW; South Texas Accelerated Research Therapeutics, San Antonio, TX, USA.; Blaydorn L; Western Regional Medical Center, Cancer Treatment Centers of America, Goodyear, AZ, USA.; Mirabella A; HonorHealth Research Institute/Translational Genomics Research Institute (TGen), Scottsdale, AZ, USA.; Beeram M; South Texas Accelerated Research Therapeutics, San Antonio, TX, USA.; Guo W; GlaxoSmithKline, Waltham, MA, USA.; Lu S; GlaxoSmithKline, Waltham, MA, USA.; Danaee H; GlaxoSmithKline, Waltham, MA, USA.; Blueprint Medicines, Cambridge, MA, USA.; McEachern K; Ribon Therapeutics, Cambridge, MA, USA.; Im E; GlaxoSmithKline, Waltham, MA, USA.; Sachdev JC; HonorHealth Research Institute/Translational Genomics Research Institute (TGen), Scottsdale, AZ, USA.
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE
Academic Journal
Patnaik A; South Texas Accelerated Research Therapeutics, San Antonio, TX 78229, USA.; Hamilton E; Breast and Gynecologic Research Program, Sarah Cannon Research Institute, Tennessee Oncology PLLC, Nashville, TN 37203, USA.; Xing Y; Department of Medical Oncology & Therapeutics Research, City of Hope National Medical Center, Duarte, CA 91010, USA.; Rasco DW; South Texas Accelerated Research Therapeutics, San Antonio, TX 78229, USA.; Smith L; South Texas Accelerated Research Therapeutics, San Antonio, TX 78229, USA.; Lee YL; Fosun Pharma USA Inc., Lexington, MA 02421, USA.; Fang S; Fosun Pharma USA Inc., Lexington, MA 02421, USA.; Wei J; Fosun Pharma USA Inc., Lexington, MA 02421, USA.; Hui AM; Fosun Pharma USA Inc., Lexington, MA 02421, USA.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Academic Journal
Goss GD; The Ottawa Hospital Research Institute and the University of Ottawa, Ottawa, Ontario, Canada.; Vokes EE; Department of Medicine, University of Chicago, Chicago, Illinois.; Gordon MS; HonorHealth Research Institute, Scottsdale, Arizona.; Gandhi L; New York University Perlmutter Cancer Center, NYU Health, New York, New York.; Papadopoulos KP; South Texas Accelerated Research Therapeutics, San Antonio, Texas.; Rasco DW; South Texas Accelerated Research Therapeutics, San Antonio, Texas.; Fischer JS; AbbVie, Inc, North Chicago, Illinois.; Chu KL; AbbVie, Inc, North Chicago, Illinois.; Ames WW; AbbVie, Inc, North Chicago, Illinois.; Mittapalli RK; AbbVie, Inc, North Chicago, Illinois.; Lee HJ; AbbVie, Inc, North Chicago, Illinois.; Zeng J; AbbVie, Inc, North Chicago, Illinois.; Roberts-Rapp LA; AbbVie, Inc, North Chicago, Illinois.; Loberg LI; AbbVie, Inc, North Chicago, Illinois.; Ansell PJ; AbbVie, Inc, North Chicago, Illinois.; Reilly EB; AbbVie, Inc, North Chicago, Illinois.; Ocampo CJ; AbbVie, Inc, North Chicago, Illinois.; Holen KD; AbbVie, Inc, North Chicago, Illinois.; Tolcher AW; South Texas Accelerated Research Therapeutics, San Antonio, Texas.
Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
Academic Journal
Gupta N; Millennium Pharmaceuticals, Inc, Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.; Hanley MJ; Millennium Pharmaceuticals, Inc, Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.; Venkatakrishnan K; Millennium Pharmaceuticals, Inc, Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.; Bessudo A; California Cancer Associates for Research and Excellence, San Diego, CA, USA.; Rasco DW; South Texas Accelerated Research Therapeutics, San Antonio, TX, USA.; Sharma S; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; O'Neil BH; Indiana University Simon Cancer Center, Indianapolis, IN, USA.; Wang B; Millennium Pharmaceuticals, Inc, Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.; Liu G; Millennium Pharmaceuticals, Inc, Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.; Ke A; Certara USA, Inc, Princeton, NJ, USA.; Patel C; Millennium Pharmaceuticals, Inc, Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.; Rowland Yeo K; Certara USA, Inc, Princeton, NJ, USA.; Xia C; Millennium Pharmaceuticals, Inc, Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.; Zhang X; Millennium Pharmaceuticals, Inc, Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.; Esseltine DL; Millennium Pharmaceuticals, Inc, Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.; Nemunaitis J; Mary Crowley Cancer Research Center, Dallas, TX, USA.
Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4604 (Electronic) Linking ISSN: 00912700 NLM ISO Abbreviation: J Clin Pharmacol Subsets: MEDLINE
Academic Journal
Tao JJ; Early Drug Development Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Cangemi NA; Early Drug Development Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Makker V; Gynecologic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Cadoo KA; Gynecologic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Liu JF; Dana-Farber Cancer Institute, Boston, Massachusetts.; Rasco DW; South Texas Accelerated Research Therapeutics, San Antonio, Texas.; Navarro WH; Atara Biotherapeutics, South San Francisco, California.; Haqq CM; Atara Biotherapeutics, South San Francisco, California.; Hyman DM; Early Drug Development Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. hymand@mskcc.org.; Department of Medicine, Weill Cornell Medical College, New York, New York.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Rasco, Drew W
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어